Glucometer, syringes and test strips for patients with diabetes Photo credit: Paul Odongo/MSF
Letter |

Open letter to Eli Lilly on barriers to accessing diabetes medicines

DIABETES
Letter to Eli Lilly
Report Cover Image
Photo credit: Paul Odongo/MSF

MSF sent this open letter to the CEO of the pharmaceutical corporation Eli Lilly highlighting our concerns about their approach to the supply and pricing of insulin, and urging action for greater access to these medicines for people living with diabetes.

UPDATE, 11 November 2024: Eli Lilly responded on 30 September 2024 with this reply letter, which we have marked up with our comments.

Read, watch, share